IVEN BOEHM: Open Payments
NPI 1790732097 · NEOGA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,030 in 57 payments from 10 companies in 2025. Trend: 2023 $936 · 2024 $1,110 · 2025 $1,030
Food & beverage: $1,030
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $204 |
| Novo Nordisk Inc | 12 | $180 |
| AstraZeneca Pharmaceuticals LP | 8 | $140 |
| GlaxoSmithKline, LLC. | 5 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $106 |
| Lilly USA, LLC | 5 | $103 |
| PFIZER INC. | 3 | $64 |
| Exact Sciences Corporation | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Viatris Specialty LLC | 1 | $24 |
Products named: OTEZLA, Ozempic, TRELEGY ELLIPTA, JARDIANCE, MOUNJARO, BREZTRI, Cologuard Collection Kit, FARXIGA.
Industry payments across IL — which companies pay providers there.
